Leo International Precision Health (LIPH) is building an active healthcare platform that unites AI-driven precision health assets across biotech, medtech, healthtech and healthcare services.
AI plays a critical role in accelerating and simplifying advanced medical diagnostics, enabling faster, more precise, and scalable clinical decision-making. To strengthen this capability at the core of its platform, LIPH has added Danner Laboratory, Inc., a U.S.-based company offering clinical laboratory testing for precision healthcare, to its portfolio.
Danner Laboratory Inc. is a clinical Cytopathology Laboratory testing service provider specializing in precision healthcare. The company offers a novel high-growth liquid biopsy Circulating Tumor Cells (CTC) and Circulating Tumor Microemboli (CTM) Cytopathology service with AI-assisted imaging analysis. This service utilizes its 2025 Edison Award CellBio technology and developing systems.
Danner Laboratory, Inc. uses cutting-edge digital diagnostic technologies, continually exploring opportunities to accelerate new precision diagnostic tools that have the potential to transform precision medicine, improving outcomes for patients and value-based healthcare providers.
Find out more about Danner Laboratory, Inc.: https://dannerlab.com/
